PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-25.76%
Negative revenue growth while ADI stands at 9.22%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-23.84%
Negative gross profit growth while ADI is at 9.27%. Joel Greenblatt would examine cost competitiveness or demand decline.
-64.30%
Negative EBIT growth while ADI is at 13.52%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-51.83%
Negative operating income growth while ADI is at 13.52%. Joel Greenblatt would press for urgent turnaround measures.
-43.99%
Negative net income growth while ADI stands at 13.92%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-38.89%
Negative EPS growth while ADI is at 83.10%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-38.89%
Negative diluted EPS growth while ADI is at 83.10%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.06%
Share change of 0.06% while ADI is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
-0.20%
Reduced diluted shares while ADI is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-3.09%
Dividend reduction while ADI stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-113.53%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-8871.43%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
86.35%
Similar 10Y revenue/share CAGR to ADI's 82.61%. Walter Schloss might see both firms benefiting from the same long-term demand.
35.01%
5Y revenue/share CAGR above 1.5x ADI's 19.00%. David Dodd would look for consistent product or market expansions fueling outperformance.
36.76%
3Y revenue/share CAGR above 1.5x ADI's 0.93%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
-222.14%
Negative 5Y OCF/share CAGR while ADI is at 335.52%. Joel Greenblatt would question the firm’s operational model or cost structure.
-166.68%
Negative 3Y OCF/share CAGR while ADI stands at 122.90%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
1100.28%
10Y net income/share CAGR of 1100.28% while ADI is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
350.91%
5Y net income/share CAGR at 50-75% of ADI's 511.33%. Martin Whitman might see a shortfall in operational efficiency or brand power.
93.82%
3Y net income/share CAGR 50-75% of ADI's 169.22%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
53.91%
5Y equity/share CAGR above 1.5x ADI's 14.55%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
101.64%
Positive short-term equity growth while ADI is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
6.40%
Dividend/share CAGR of 6.40% while ADI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
40.10%
3Y dividend/share CAGR of 40.10% while ADI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-1.06%
Firm’s AR is declining while ADI shows 5.02%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
1.41%
Inventory shrinking or stable vs. ADI's 9.58%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
-1.01%
Negative asset growth while ADI invests at 30.73%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
3.26%
Under 50% of ADI's 6.89%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
37.42%
Debt shrinking faster vs. ADI's 319.17%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
No Data
No Data available this quarter, please select a different quarter.
-36.28%
We cut SG&A while ADI invests at 1.04%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.